ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

17.47
Delayed Data
As of 4:00pm ET
 +0.47 / +2.76%
Today’s Change
14.51
Today|||52-Week Range
41.20
-41.98%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close17.00
Today’s open16.97
Day’s range16.61 - 17.70
Volume2,002,503
Average volume (3 months)2,813,305
Market cap$2.4B
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-0.85%
Earnings growth (this year)+28.92%
Earnings growth (next 5 years)-68.62%
Revenue growth (last year)+620.68%
P/E ratioNM
Price/Sales29.56
Price/Book7.10

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.73-1.48%
AKRXAkorn Inc+0.30+2.19%
----
MNKMallinckrodt Plc+0.11+0.67%
Data as of 4:02pm ET, 05/24/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$124.9M
Annual profit (last year)-$289.4M
Net profit margin-231.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Senior VP-Strategy &
Technology Operations
Bob Mischler
Corporate headquarters
San Diego, California

Forecasts